News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
130 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Abaxis to Report Third Quarter Fiscal Year 2018 Financial Results on Thursday, January 25, 2018
The call will be at 4:15 p.m. ET on Thursday, January 25, 2018.
January 17, 2018
·
1 min read
Policy
3M Submits 510(k) Application for 24-Minute Readout for Steam Sterilization Assurance
3M announced today its submission for 510(k) clearance with the FDA for its Attest Super Rapid System for Steam Sterilization, which will provide biological indicator (BI) results in 24 minutes.
January 17, 2018
·
2 min read
GastroGeniX Collaborates With the University of Saskatchewan on Patent License to Advance Capsule Endoscopy
GastroGeniX and the University Of Saskatchewan have reached an agreement to License United States Patent 9,088,716B2, and all associated intellectual properties, to GastroGenix Inc.
January 17, 2018
·
3 min read
Business
Aeon Global Health Announces Exclusive Marketing and Sales Agreement for Trusted Branded Pharmaceutical
Under the agreement, Aeon will become the exclusive clinical laboratory marketing representative of Sabal and will market the drug alongside of its industry-leading drug monitoring service.
January 17, 2018
·
4 min read
Business
Chronicled Announces LinkLab Executives to Join Executive Leadership Team
Chronicled today announced the addition of Susanne Somerville and Eric Garvin to its executive team
January 17, 2018
·
2 min read
Business
Dr. Gaetano Morelli Joins Altasciences Clinical Research’s Medical Team
Dr. Morelli has over two decades of experience in clinical research, Phases I to III, as a Principal Investigator and Medical Director.
January 17, 2018
·
2 min read
Business
PositiveID’s E-N-G Mobile Systems 2017 Bookings Increase 100% Year Over Year
ENG’s mobile labs represent the fastest growing segment of ENG’s specialty vehicle business.
January 17, 2018
·
3 min read
Biotech Bay
Marrone Bio Innovations Announces the Launch of Zelto for Control of Foliar and Soil Dwelling Pests on Turf
Zelto promotes turf health by protecting roots from the ground up additional turf uses for nematode control are allowed.
January 17, 2018
·
4 min read
Drug Development
Gemphire Completes Patient Enrollment in INDIGO-1 Trial in Severe Hypertriglyceridemia (SHTG) Patients
The Company remains on track to report top-line results from the study in the second quarter of 2018.
January 17, 2018
·
9 min read
Drug Development
Amarin Announces Commencement of VASCEPA Clinical Development in Mainland China
Under the parties’ February 2015 agreement, Eddingpharm is responsible for Vascepa development, regulatory activities, commercialization and associated costs, including managing and funding this pivotal registration study.
January 17, 2018
·
8 min read
Previous
3 of 13
Next